CB839-assisted preferential infection and replication of oncolytic adenovirus for enhanced oncolytic virotherapy
Chinese Chemical Letters · 2026-05 · 113013
DOI: 10.1016/j.cclet.2026.113013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-05. Verfasst von Weiyue Ban und 8 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning Revitalization Talents Program, Shenyang Pharmaceutical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Liaoning Revitalization Talents Program
- Shenyang Pharmaceutical University
- National Key Research and Development Program of China
Zitieren
APA
Ban, W., Yang, S., Chen, Z., Jiang, H., Huang, Y., Cheng, Z., He, Z., Sun, M., & Sun, J. (2026). CB839-assisted preferential infection and replication of oncolytic adenovirus for enhanced oncolytic virotherapy. Chinese Chemical Letters, 113013. https://doi.org/10.1016/j.cclet.2026.113013
Vancouver
Ban W, Yang S, Chen Z, Jiang H, Huang Y, Cheng Z, et al. CB839-assisted preferential infection and replication of oncolytic adenovirus for enhanced oncolytic virotherapy. Chinese Chemical Letters. 2026:113013. doi:10.1016/j.cclet.2026.113013
BibTeX
@article{Ban2026,
author = {Ban, Weiyue and Yang, Shihua and Chen, Zhichao and Jiang, Hai and Huang, Yuyao and Cheng, Zhenguo and He, Zhonggui and Sun, Mengchi and Sun, Jin},
title = {CB839-assisted preferential infection and replication of oncolytic adenovirus for enhanced oncolytic virotherapy},
journal = {Chinese Chemical Letters},
year = {2026},
pages = {113013},
doi = {10.1016/j.cclet.2026.113013}
}
EUVIMED